Cardiovascular and Metabolic Comorbidities in Patients with Thyroid Nodules: the Impact of Incidental Diagnosis

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 2023 Sep 13

PMID 37702926

Authors

L Croce

R M Ruggeri

C Cappelli

C Virili

F Coperchini

M Lagana

P Costa

M Dal Molin

S Chytiris

F Magri

L Chiovato

M Centanni

S Cannavo

M Rotondi

Affiliations

Soon will be listed here.

Abstract

Purpose: The prevalence of thyroid nodules (TN) in the general population has increased as screening procedures are implemented and an association with metabolic and cardiovascular disorders has been reported. The aim of this study was to investigate the reason leading to the diagnosis of TN and to compare the clinical characteristics of patients diagnosed incidentally with those of patients diagnosed for thyroid-related reasons.

Methods: We designed a retrospective cross-sectional study including consecutive patients with TN from two high-volume hospital-based centers for thyroid diseases (Pavia and Messina) in Italy. Data regarding reason leading to TN diagnosis, age, sex, BMI, presence of cardio-metabolic comorbidities were collected.

Results: Among the 623 enrolled subjects, the US diagnosis of TN was prompted by thyroid-related reasons in 421 (67.6%, TD group) and incidental in 202 (32.4%, ID group) with a similar distribution in the two centers (p = 0.960). The ID group patients were more frequently males (38.6% vs 22.1%, p < 0.001) and significantly older (58.9 ± 13.7 vs 50.6 ± 15.5 years, p < 0.001) than the TD group ones, and had a higher rate of cardiovascular comorbidities (73.8% vs 47.5%, p < 0.001), despite having a similar BMI (27.9 ± 5.2 vs 27.8 ± 13.5, p = 0.893).

Conclusions: Stratification of patients with TN according to the diagnostic procedure leading to diagnosis allows a better epidemiological characterization of this inhomogeneous and large population.

Citing Articles

Differences and analogies in thyroid cancer discovered incidentally or by thyroid related screening: A multicenter study.

Croce L, Ruggeri R, Virili C, Cappelli C, Teliti M, Costa P Eur Thyroid J. 2025; .

PMID: 39841635 PMC: 11825167. DOI: 10.1530/ETJ-24-0190.

Management of Giant Thyroid Tumors in Patients with Multiple Comorbidities in a Tertiary Head and Neck Surgery Center.

Vrinceanu D, Dumitru M, Marinescu A, Serboiu C, Musat G, Radulescu M Biomedicines. 2024; 12(10).

PMID: 39457517 PMC: 11504648. DOI: 10.3390/biomedicines12102204.

Deciphering the progression of fine-needle aspiration: A bibliometric analysis of thyroid nodule research.

Liu T, Yang F, Qiao J, Mao M Medicine (Baltimore). 2024; 103(20):e38059.

PMID: 38758913 PMC: 11098219. DOI: 10.1097/MD.0000000000038059.

Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs.

Greco A, Coperchini F, Croce L, Magri F, Teliti M, Rotondi M Front Pharmacol. 2023; 14:1303844.

PMID: 38146457 PMC: 10749369. DOI: 10.3389/fphar.2023.1303844.

References

Dean D, Gharib H . Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2008; 22(6):901-11. DOI: 10.1016/j.beem.2008.09.019. View

Olivieri A, Ando S, Bagnasco M, Meringolo D, Mian C, Moleti M . The iodine nutritional status in the Italian population: data from the Italian National Observatory for Monitoring Iodine Prophylaxis (OSNAMI) (period 2015-2019). Am J Clin Nutr. 2019; 110(5):1265-1266. DOI: 10.1093/ajcn/nqz206. View

Zhang F, Teng D, Tong N, Wang G, Li Y, Yu X . Gender-Specific Associations Between Metabolic Disorders and Thyroid Nodules: A Cross-Sectional Population-Based Study from China. Thyroid. 2022; 32(5):571-580. DOI: 10.1089/thy.2021.0686. View

Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L, Jorgensen T . Risk factors for goiter and thyroid nodules. Thyroid. 2002; 12(10):879-88. DOI: 10.1089/105072502761016502. View

Han J, Kim T, Jeon M, Yim J, Kim W, Song D . Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol. 2013; 168(6):879-86. DOI: 10.1530/EJE-13-0065. View

Olivieri A, Trimarchi F, Vitti P . Global iodine nutrition 2020: Italy is an iodine sufficient country. J Endocrinol Invest. 2020; 43(11):1671-1672. DOI: 10.1007/s40618-020-01402-6. View

Aydogan Y, Altay M, Unsal O, Kaplanoglu V, Cagir Y, Yildiz C . An assessment of the relationship between thyroid nodule characteristics, insulin resistance and arterial stiffness in euthyroid nodular goiter. Endocrine. 2018; 62(2):440-447. DOI: 10.1007/s12020-018-1701-6. View

Buscemi S, Massenti F, Vasto S, Galvano F, Buscemi C, Corleo D . Association of obesity and diabetes with thyroid nodules. Endocrine. 2017; 60(2):339-347. DOI: 10.1007/s12020-017-1394-2. View

Dal Maso L, Panato C, Franceschi S, Serraino D, Buzzoni C, Busco S . The impact of overdiagnosis on thyroid cancer epidemic in Italy,1998-2012. Eur J Cancer. 2018; 94:6-15. DOI: 10.1016/j.ejca.2018.01.083. View

10.

Su Y, Zhang Y, Zhao M, Zhang H, Zhang X, Guan Q . Association Between Thyroid Nodules and Volume and Metabolic Syndrome in an Iodine-Adequate Area: A Large Community-Based Population Study. Metab Syndr Relat Disord. 2019; 17(4):217-222. DOI: 10.1089/met.2018.0094. View

11.

Liu F, Zhang X . Hypertension and Obesity: Risk Factors for Thyroid Disease. Front Endocrinol (Lausanne). 2022; 13:939367. PMC: 9339634. DOI: 10.3389/fendo.2022.939367. View

12.

Anil C, Akkurt A, Ayturk S, Kut A, Gursoy A . Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area. Metabolism. 2013; 62(7):970-5. DOI: 10.1016/j.metabol.2013.01.009. View

13.

Grani G, Sponziello M, Pecce V, Ramundo V, Durante C . Contemporary Thyroid Nodule Evaluation and Management. J Clin Endocrinol Metab. 2020; 105(9). PMC: 7365695. DOI: 10.1210/clinem/dgaa322. View

14.

Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu N . Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol. 2009; 161(4):599-605. DOI: 10.1530/EJE-09-0410. View

15.

Xu L, Zeng F, Wang Y, Bai Y, Shan X, Kong L . Prevalence and associated metabolic factors for thyroid nodules: a cross-sectional study in Southwest of China with more than 120 thousand populations. BMC Endocr Disord. 2021; 21(1):175. PMC: 8400405. DOI: 10.1186/s12902-021-00842-2. View

16.

Zhang F, Li Y, Yu X, Wang X, Lin Z, Song B . The Relationship and Gender Disparity Between Thyroid Nodules and Metabolic Syndrome Components Based on a Recent Nationwide Cross-Sectional Study and Meta-Analysis. Front Endocrinol (Lausanne). 2021; 12:736972. PMC: 8490942. DOI: 10.3389/fendo.2021.736972. View

17.

Haymart M, Banerjee M, Reyes-Gastelum D, Caoili E, Norton E . Thyroid Ultrasound and the Increase in Diagnosis of Low-Risk Thyroid Cancer. J Clin Endocrinol Metab. 2018; 104(3):785-792. PMC: 6456891. DOI: 10.1210/jc.2018-01933. View

18.

Wang K, Yang Y, Wu Y, Chen J, Zhang D, Mao X . The association between insulin resistance and vascularization of thyroid nodules. J Clin Endocrinol Metab. 2014; 100(1):184-92. DOI: 10.1210/jc.2014-2723. View

19.

Tang Y, Yan T, Wang G, Chen Y, Zhu Y, Jiang Z . Correlation between Insulin Resistance and Thyroid Nodule in Type 2 Diabetes Mellitus. Int J Endocrinol. 2017; 2017:1617458. PMC: 5660821. DOI: 10.1155/2017/1617458. View

20.

Mu C, Ming X, Tian Y, Liu Y, Yao M, Ni Y . Mapping global epidemiology of thyroid nodules among general population: A systematic review and meta-analysis. Front Oncol. 2022; 12:1029926. PMC: 9685339. DOI: 10.3389/fonc.2022.1029926. View